ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,204 | -36.2% | 1,957 | 0.0% | 0.01% | -28.6% |
| Q2 2023 | $9,726 | +0.6% | 1,957 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $9,668 | -21.5% | 1,957 | 0.0% | 0.01% | -22.2% |
| Q4 2022 | $12,310 | -61.5% | 1,957 | -34.3% | 0.01% | -65.4% |
| Q3 2022 | $32,000 | -5.9% | 2,977 | 0.0% | 0.03% | +4.0% |
| Q2 2022 | $34,000 | +25.9% | 2,977 | 0.0% | 0.02% | +66.7% |
| Q1 2022 | $27,000 | -34.1% | 2,977 | +7.5% | 0.02% | -31.8% |
| Q4 2021 | $41,000 | -46.1% | 2,769 | -6.8% | 0.02% | -51.1% |
| Q3 2021 | $76,000 | -17.4% | 2,972 | -16.0% | 0.04% | -11.8% |
| Q2 2021 | $92,000 | -39.5% | 3,537 | -17.6% | 0.05% | -45.7% |
| Q1 2021 | $152,000 | – | 4,293 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |